Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

BIOMARIN PHARMACEUTICAL INC.

(BMRN)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur BIOMARIN PHARMACEUTICAL INC.
30/11BIOMARIN TO HOLD VIRTUAL R&D DAY AT : 00am ET Today
29/11BioMarin to Participate in Two Upcoming Virtual Investor Conferences
23/11INVESTIGATION REMINDER : The Schall Law Firm Announces it is Investigating Claims Against ..
23/11INVESTIGATION ALERT : The Schall Law Firm Announces it is Investigating Claims Against Bio..
19/11BioMarin Gets FDA Approval for Voxzogo in Pediatric Patients With Bone Growth Disorder;..
19/11FDA OKs BioMarin's Voxzogo for Children With Most Common Form of Dwarfism
19/11BioMarin Receives FDA Approval for VOXZOGO™ (vosoritide) for Injection, Indicated..
19/11Biomarin Pharmaceutical Inc. Receives FDA Approval for Voxzogo? for Injection
18/11Novartis Said Considering Takeover in Biotech Sector
15/11Entos and BioMarin Enter into Agreement for Product Candidates Incorporating Entos' Fus..
03/11BIOMARIN PHARMACEUTICAL INC : Change in Directors or Principal Officers (form 8-K)
03/11BioMarin Pharmaceutical Inc. Announces Management Changes, Effective January 28, 2022
01/11SHAREHOLDER ALERT : Robbins LLP Announces that BioMarin Pharmaceutical Inc. (BMRN) is Bein..
29/10BIOMARIN PHARMACEUTICAL INC Management's Discussion and Analysis of Financial Conditio..
27/10BioMarin Pharmaceutical Posts Q3 Net Loss, Reversing Year-Ago Profit
27/10BIOMARIN : Q3 Earnings Snapshot
27/10BioMarin Announces Third Quarter 2021 Financial Results and Corporate Updates - Form 8-..
27/10Earnings Flash (BMRN) BIOMARIN PHARMACEUTICAL Reports Q3 Revenue $408.7M
27/10BioMarin Pharmaceutical Inc. Revises Earnings Guidance for the Full Year 2021
27/10BioMarin Announces Third Quarter 2021 Financial Results and Corporate Updates
27/10BioMarin Pharmaceutical Inc. Reports Earnings Results for the Third Quarter and Nine Mo..
25/10BIOMARIN PHARMACEUTICAL : to Participate in Four Upcoming Virtual Investor Conferences
12/10BIOMARIN TO HOST THIRD QUARTER 2021 : 30pm ET
04/10BIOMARIN PHARMACEUTICAL : Hires Industry Veterans to Fill Key Roles in R&D and Technical O..
04/10BioMarin Pharmaceutical Inc. Hires Harold S. Bernstein as Chief Medical Officer and Hea..
20/09SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioMa..
10/09SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioMa..
09/09A step closer to tapering
09/09ANALYST RECOMMENDATIONS : Boohoo, Boston Beer, Cisco Systems, Eversource, Frontline...
07/09Health Care Down As Rally In Sector Pauses -- Health Care Roundup
07/09PPG Industries, BioMarin fall; AMC, Callaway Golf rise
07/09Wall Street sluit overwegend lager
07/09MÄRKTE USA/Wall Street von Gewinnmitnahmen gedrückt - Nasdaq mit Rekord
07/09Health Care Stocks Falling This Afternoon
07/09MÄRKTE USA/Gewinnmitnahmen an Wall Street - Nasdaq mit Rekordhoch
07/09Health Care Stocks Flat To Lower Pre-Bell Tuesday
07/09BIOMARIN PHARMACEUTICAL : Health Care
07/09BIOMARIN PHARMACEUTICAL : Says FDA Orders Clinical Hold on Phase 1/2 Gene Therapy Trial in..
06/09BIOMARIN PHARMACEUTICAL : U.S. FDA Placed a Clinical Hold on BMN 307 Phearless Phase 1/2 G..
06/09Biomarin Pharmaceutical Inc. Announces U.S. FDA Placed Clinical Hold on BMN 307 Phearle..
30/08BIOMARIN PHARMACEUTICAL : European Commission Approves BioMarin's VOXZOGO (vosoritide) for..
27/08BIOMARIN PHARMACEUTICAL : European Commission Approves BioMarin's VOXZOGO® (vosoritide) fo..
27/08European Commission Approves BioMarin’s VOXZOGO for the Treatment of Children with Acho..
27/08BIOMARIN PHARMACEUTICAL : Receives European Commission Marketing Authorization for Voxzogo
27/08BIOMARIN PHARMACEUTICAL : drug wins Europe's first approval for type of dwarfism
27/08BIOMARIN PHARMACEUTICAL : Europe clears Biomarin drug for type of dwarfism in region's fir..
27/08BIOMARIN PHARMACEUTICAL : European Commission Approves BioMarin's VOXZOGO® (vosoritide) fo..
27/08BioMarin Gets European Commission Approval for Voxzogo
25/08BIOMARIN PHARMACEUTICAL : to Participate in Three Upcoming Virtual Investor Conferences
04/08INSIDER TRENDS : 90-Days of Insider Buying at BioMarin Pharmaceuticals Eased Back with Sha..
30/07BIOMARIN PHARMACEUTICAL : Management's Discussion and Analysis of Financial Condition and ..
28/07BIOMARIN : Q2 Earnings Snapshot
28/07BIOMARIN PHARMACEUTICAL : Debra Charlesworth (Form 8-K)
28/07BIOMARIN PHARMACEUTICAL : Pharma Swings to Q2 Profit on Rising Revenue, Raises Full-Year G..
28/07Biomarin Pharmaceutical Inc. Raises Earnings Guidance for the Full Year of 2021
28/07BIOMARIN PHARMACEUTICAL : Announces Second Quarter 2021 Financial Results and Corporate Up..
28/07BIOMARIN PHARMACEUTICAL : Earnings Flash (BMRN) BIOMARIN PHARMACEUTICAL Reports Q2 Revenue..
28/07EARNINGS REACTION HISTORY : Biomarin Pharmaceutical, 33.3% Follow-Through Indicator, 2.2% ..
22/07BIOMARIN PHARMACEUTICAL : Announces Oral Presentation at International Society
21/07BIOMARIN PHARMACEUTICAL : Pharma's Gene Therapy Candidate Shows Bleed Control Over Five Ye..
21/07BIOMARIN PHARMACEUTICAL : Announces Oral Presentation at International Society on Thrombos..
21/07BioMarin Pharmaceutical Inc. Announces Unaudited Consolidated Earnings Results for the ..
20/07BIOMARIN PHARMACEUTICAL : Announces Oral Presentation of Positive One-Year Results from Ph..
19/07BIOMARIN PHARMACEUTICAL : Announces Oral Presentation of Positive One-Year Results from Ph..
19/07BioMarin Announces Oral Presentation of Positive One-Year Results from Phase 3 Pivotal ..
15/07BIOMARIN PHARMACEUTICAL : European Regulator Accepts BioMarin's Marketing Application for ..
15/07BIOMARIN PHARMACEUTICAL : European Medicines Agency Validates BioMarin's Marketing Authori..
15/07European Medicines Agency Validates Biomarin's Marketing Authorization Application for ..
14/07BIOMARIN TO HOST SECOND QUARTER 2021 : 30pm ET
05/07BIOMARIN PHARMACEUTICAL : Findings to be Presented from Ongoing Studies of Valoctocogene R..
02/07BIOMARIN PHARMACEUTICAL : Announces 12 Presentations at the International Society on Throm..
02/07BIOMARIN PHARMACEUTICAL : Plaintiff Cannot Amend Statement Of Claim More Than 45 Days Afte..
29/06BIOMARIN PHARMACEUTICAL : - Valoctocogene Roxaparvovec MAA Granted Request for Accelerated..
28/06BIOMARIN PHARMACEUTICAL : Resubmits European Marketing Authorization Application for Gene ..
28/06BIOMARIN PHARMACEUTICAL : Resubmits Marketing Authorization Application (MAA) to European ..
1  2  3  4  5  6  7  8  9  10Suiv.
Prochain événement sur BIOMARIN PHARMACEUTICAL INC.